These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19806433)

  • 1. The influence of flow rate on the aerosol deposition profile and electrostatic charge of single and combination metered dose inhalers.
    Hoe S; Traini D; Chan HK; Young PM
    Pharm Res; 2009 Dec; 26(12):2639-46. PubMed ID: 19806433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction of the electrical next generation impactor (eNGI) and investigation of its capabilities for the study of pressurized metered dose inhalers.
    Hoe S; Young PM; Chan HK; Traini D
    Pharm Res; 2009 Feb; 26(2):431-7. PubMed ID: 19015961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring The Bipolar Charge Distributions of Fine Particle Aerosol Clouds of Commercial PMDI Suspensions Using a Bipolar Next Generation Impactor (bp-NGI).
    Rowland M; Cavecchi A; Thielmann F; Kulon J; Shur J; Price R
    Pharm Res; 2018 Nov; 36(1):15. PubMed ID: 30478630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
    Aubier M; Pieters WR; Schlösser NJ; Steinmetz KO
    Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-deposition of salmeterol and fluticasone propionate by a combination inhaler.
    Theophilus A; Moore A; Prime D; Rossomanno S; Whitcher B; Chrystyn H
    Int J Pharm; 2006 Apr; 313(1-2):14-22. PubMed ID: 16516417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations into the formulation of metered dose inhalers of salmeterol xinafoate and fluticasone propionate microcrystals.
    Murnane D; Martin GP; Marriott C
    Pharm Res; 2008 Oct; 25(10):2283-91. PubMed ID: 18509598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring charge and mass distributions in dry powder inhalers using the electrical Next Generation Impactor (eNGI).
    Hoe S; Traini D; Chan HK; Young PM
    Eur J Pharm Sci; 2009 Sep; 38(2):88-94. PubMed ID: 19559086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.
    Nelson HS; Wolfe JD; Gross G; Greos LS; Baitinger L; Scott C; Dorinsky P
    Ann Allergy Asthma Immunol; 2003 Sep; 91(3):263-9. PubMed ID: 14533658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life.
    Edin HM; Andersen LB; Schoaf L; Scott-Wilson CA; Ho SY; Ortega HG
    Ann Allergy Asthma Immunol; 2009 Apr; 102(4):323-7. PubMed ID: 19441604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic bioavailability of hydrofluoroalkane (HFA) formulations of fluticasone/salmeterol in healthy volunteers via pMDI alone and spacer.
    Clearie KL; Williamson PA; Vaidyanathan S; Du Bois J; Nell H; Lipworth BJ
    Br J Clin Pharmacol; 2010 Jun; 69(6):637-44. PubMed ID: 20565455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
    Chapman KR; Ringdal N; Backer V; Palmqvist M; Saarelainen S; Briggs M
    Can Respir J; 1999; 6(1):45-51. PubMed ID: 10202220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler.
    Van Holsbeke C; De Backer J; Vos W; Marshall J
    Ther Adv Respir Dis; 2018; 12():1753466618760948. PubMed ID: 29499614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new fixed dose combination of fluticasone and formoterol in a pressurised metered-dose inhaler for the treatment of asthma].
    Devillier P; Salvator H; Grassin-Delyle S; Naline E; Advenier C; Roche N
    Rev Mal Respir; 2014 Oct; 31(8):700-13. PubMed ID: 25391505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous quantitative determinations of fluticasone propionate and salmeterol xinafote in diskus inhalers.
    Duran A; Dogan HN; Ulgen M
    Drug Metab Lett; 2014; 8(1):31-5. PubMed ID: 25313021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 'stage-by-stage' deposition of drugs from commercial single-active and combination dry powder inhaler formulations.
    Taki M; Ahmed S; Marriott C; Zeng XM; Martin GP
    Eur J Pharm Sci; 2011 Jul; 43(4):225-35. PubMed ID: 21549837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the efficacy and safety of salmeterol/fluticasone pMDI versus its mono-components, other LABA/ICS pMDIs and salmeterol/fluticasone Diskus in patients with asthma.
    Mehta N; Aggarwal B; Gogtay J; Abdool-Gaffar S
    Expert Opin Drug Deliv; 2015 Jun; 12(6):963-75. PubMed ID: 25429610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma.
    Doull I; Price D; Thomas M; Hawkins N; Stamuli E; Tabberer M; Gosden T; Rudge H
    Curr Med Res Opin; 2007 May; 23(5):1147-59. PubMed ID: 17519082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma.
    Van den Berg NJ; Ossip MS; Hederos CA; Anttila H; Ribeiro BL; Davies PI
    Pediatr Pulmonol; 2000 Aug; 30(2):97-105. PubMed ID: 10922131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.